Human T-lymphotropic virus type i or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): Two case reports

Journal of NeuroVirology

Volumn 16, Issue 3, 2010, Pages 249-253

  Delgado, Silvia R ^a   Sheremata, William A ^a   Brown, Andrew D ^a   McCarthy, Micheline ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CNS demyelinating diseases; Devic's disease; HTLV I II; Longitudinally extensive transverse myelitis; Myelopathy; Neuromyelitis optica; NMO

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; DEXAMETHASONE; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERFERON BETA SERINE; METHYLPREDNISOLONE; MITOXANTRONE; RITUXIMAB;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; CASE REPORT; DEMYELINATION; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMIPARESIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOPATHOGENESIS; INTRAVENOUS DRUG ABUSE; LAMINECTOMY; MALE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; QUADRIPLEGIA; RETROVIRUS; SPINAL CORD ATROPHY; SPINE TUMOR; VIRUS IDENTIFICATION;

ATROPHY; FEMALE; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELITIS, TRANSVERSE; SPINAL CORD;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77953228366     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550281003801493     Document Type: Article

References (24)

1. Araujo A, Silva MT (2006). The HTLV-1 neurological complex. Lancet Neurol 5: 1068-1076.
2. Araujo A, Hall W (2004). Human T-lymphotropic virus type II and neurological disease. Ann Neurol 56: 10-19.
3. Blanche P, Diaz E, Gombert B, Sicard D (2000). Devic's neuromyelitis optica and HIV-1 infection [Letters to the Editor]. J Neurol Neurosurg Psychiatry 68: 795.
4. Godoy AJ, Kira J, Hasuo K, Goto I (1995). Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen vasculitis: a semi-quantitative MRI study. J Neurol Sci 133: 102-111.
5. Harrington WJ Jr, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SK, Snodgrass S, Toedter G, Cabral L, Poiesz B (1993). Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 33: 411-414. (Pubitemid 23103978)
6. Izumo S, Goto I, Itoyama Y, et al. (1996). Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicen-ter, randomized, double-blind, controlled trial. Neurology 46: 1016-1021.
7. Jacobson S (2002). Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186(Suppl 2): S187-S192.
8. Jacobson S, Lehky T, Nishimura M, Robinson S, et al. (1993). Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 33: 392-396.
9. Kasahata N, Shiota J, Miyazawa Y, et al. (2003). Acute human T-lymphotropic virus type 1-associated myelop-athy. Arch Neurol 60: 873-876.
10. Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K (1991). Leukoencephalopathy in HTLV-I-associated myelopa-thy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy. J Neurol Sci 106: 41-49.
11. Koga M, Takahashi T, Kawai M, Negoro K, Kanda T (2009). Neuromyelitis optica with HTLV-I infection: different from acute progressive HAM? Intern Med 48: 1157-1159.
12. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. (2004). A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
13. Mochizuki M, Watanabe T, Yamaguchi K, et al. (1992). HTLV-1 uveitis: a distinct clinical entity caused by HTLV-1. Jpn J Cancer Res 83: 236-239.
14. Morgan D, Caskey M, Abbehusen C, et al. (2007). Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP. AIDS Res Hum Retroviruses 23: 1499-1504.
15. Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989). HTLV-1 and polymyositis in Jamaica. Lancet 2: 1184-1187.
16. Sheremata W, Berger J, Harrington WJ Jr, et al. (1992). Human T lymphotropic virus type I-associated myelop-athy. A report of 10 patients born in the United States. Arch Neurol 49: 1113-1118.
17. TakenouchiN, YaoK, Jacobson S (2004). Immunopathogen-esis of HTLV-I associated neurological disease: molecular, histopathologic, and immunologic approaches. Frontiers Biosci 9: 2527-2539.
18. Umehara F, Nose H, Saito M, et al. (2007). Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. J NeuroVirol 13: 260-267.
19. Unsong Oh, Yoshihisa Y, Mora C, et al. (2005). Interferon-b 1a Therapy in Human T-Lymphotropic Virus type I-associated neurological disease. Ann Neurol 57: 526-534.
20. Vernant JC, Buisson GG, Sobesky G, Arfi S, Gervaise G, Roman GC (1987). Can HTLV-1 lead to immunological disease [letter]? Lancet 2: 404.
21. Wingerchuk DM (2006). Neuromyelitis optica. Int MS J 13: 42-50.
22. Wingerchuk DM (2007). Diagnosis and treatment of neu-romyelitis optica. Neurologist 13: 2-11.
23. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007). The spectrum of neuromyelitis optica. Lancet Neurol 6: 805-815.
24. Wingerchuk DM, Weinshenker BG (2008). Neuromyelitis optica. Curr Treat Options Neurology 10: 55-66.